Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

1910 Genetics Inc.

Headquarters: Boston, MA, United States of America
Year Founded: 2018
Status: Private

BioCentury | Nov 17, 2023
Management Tracks

FDA chief of staff shifting to CBER

Plus: Biden to appoint Kimryn Rathmell as NCI’s director and updates from 1910 and Chimerix
BioCentury | Oct 17, 2023
Finance

Playground Global’s on-ramp for first-time founders 

Via early-stage biotech financing, the firm focuses on data-generating platforms and best-in-class lead assets
BioCentury | Oct 12, 2022
Management Tracks

Wiggins, Simon join C-suite at Vaxcyte

Plus AZ’s Sheldon joining GSK (at last) and updates from Sudo, Walden, 1910 and more
BioCentury | Mar 24, 2021
Deals

March 23 Quick Takes: Moulder’s Zenas launches; plus PhoreMost, 1910 Genetics, XyloCor and Catalent

Lonnie Moulder’s cross-border biotech Zenas BioPharma launched Tuesday to develop immune-based therapies. Moulder, the co-founder and CEO of Tesaro Inc., is executive chairman and interim CEO
Items per page:
1 - 4 of 4